Allakos (ALLK) IPO Opens 51% Higher

Today's IPO for Allakos Inc., (Nasdaq: ALLK) opened for trading at $27.20 after pricing 7,133,333 shares of its common stock at a public offering price of $18.00 per share.

In addition, Allakos has granted the underwriters a 30-day option to purchase up to 1,069,999 additional shares of common stock at the initial public offering price less underwriting discounts and commissions.

Goldman Sachs & Co. LLC and Jefferies LLC are acting as joint book-running managers for the offering. William Blair & Company, L.L.C. is acting as the lead manager for the offering.

Allakos is a clinical stage biotechnology company focused on the development of antibodies for the treatment of various eosinophil and mast cell related diseases.

You May Also Be Interested In

• YPF Energía Eléctrica S.A. files for proposed NYSE IPO
• NextCure and Avere to merge, targeting oral IL-23 therapy
• Alto Neuroscience prices $100M stock offering to fund depression trial